| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 87811 |
Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) |
4,182 |
3,359 |
$93K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
4,287 |
3,418 |
$85K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
1,903 |
1,516 |
$57K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
1,916 |
1,564 |
$52K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
520 |
428 |
$23K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
1,020 |
739 |
$10K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
1,786 |
800 |
$6K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
1,813 |
1,538 |
$6K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
248 |
187 |
$2K |
| 99202 |
Office or other outpatient visit for the evaluation and management of a new patient, straightforward |
19 |
15 |
$186.83 |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
21 |
14 |
$163.17 |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
13 |
12 |
$35.24 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
70 |
48 |
$25.49 |